スポンサーリンク
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc | 論文
- Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library
- YM-216391, a Novel Cytotoxic Cyclic Peptide from Streptomyces nobilis : I. Fermentation, Isolation and Biological Activities
- Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 : III. In Vitro and In Vivo Antitumor Activities
- Absolute Quantification of Four Isoforms of the Class I Phosphoinositide-3-kinase Catalytic Subunit by Real-Time RT-PCR(Communications to the Editor)
- Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines
- Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines
- Marine Diterpenoids with a Briarane Skeleton from the Okinawan Soft Coral Pachyclavularia violacea
- Identification of JTP-70902, a p15^-inductive compound, as a novel MEK1/2 inhibitor
- Identification of Interleukin-6 as a Factor That Induces Neurite Outgrowth by PC12 Cells Primed with NGF^1
- A Novel Differentiation Factor for PC12 Cells from Culture Supernatant of Mouse Hepatocyte Cell Line MLE-15A2
- Establishment of a Hepatocyte Cell Line Producing Growth-promoting Factors for Liver-colonizing Tumor Cells
- Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116 Cells(Highlighted paper selected by Editor-in-chief,Miscellaneous)
- Sesquiterpenoids and Flavonoids from the Aerial Parts of Tithonia diversifolia and Their Cytotoxic Activity
- Motif-programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria
- Phosphatidylinositol 3-kinase inhibitors : promising drug candidates for cancer therapy
- Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase(Pharmacology)
- Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo
- ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms
- Development of an Immunohistochemical Protein Quantification System in Conjunction with Tissue Microarray Technology for Identifying Predictive Biomarkers for Phosphatidylinositol 3-Kinase Inhibitors
- Search for Novel Anti-tumor Agents from Ridaifens Using JFCR39, a Panel of Human Cancer Cell Lines
スポンサーリンク